Title: | Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza A and B in the 2014-2015 to 2016-2017 influenza seasons in Japan |
Authors: | Ishiguro, Nobuhisa Browse this author →KAKEN DB |
Koseki, Naoko Browse this author |
Kaiho, Miki Browse this author |
Ariga, Tadashi Browse this author →KAKEN DB |
Kikuta, Hideaki Browse this author |
Oba, Koji Browse this author →KAKEN DB |
Togashi, Takehiro Browse this author |
Morita, Keisuke Browse this author |
Inagawa, Akira Browse this author |
Okamura, Akiko Browse this author |
Yamazaki, Shigeru Browse this author |
Shida, Satoru Browse this author |
Konno, Mutsuko Browse this author |
Kawamura, Nobuaki Browse this author →KAKEN DB |
Ishizaka, Akihito Browse this author |
Takada, Kimihiko Browse this author |
Tsubakihara, Keiji Browse this author |
Nagano, Naoko Browse this author |
Shibata, Mutsuo Browse this author |
Furuyama, Hideto Browse this author |
Matsuzono, Yoshihiro Browse this author |
Koike, Akemi Browse this author |
Murashita, Mari Browse this author |
Hatae, Yoshio Browse this author |
Arioka, Hideki Browse this author |
Yamanaka, Tatsuru Browse this author |
Watanabe, Toru Browse this author |
Tabata, Yuuichi Browse this author |
Kumita, Yoshihiro Browse this author |
Hazama, Kyosuke Browse this author |
Akutsu, Yasushi Browse this author |
Aoyagi, Hayato Browse this author |
Tobise, Chie Browse this author |
Azuma, Katsuki Browse this author |
Yasoshima, Kohichi Browse this author |
Sawada, Yoko Browse this author |
Uetsuji, Kazuyuki Browse this author |
Tsuchida, Akira Browse this author |
Tsuchiyama, Akira Browse this author |
Yasuda, Kazue Browse this author |
Odagawa, Yasuhisa Browse this author |
Yoshioka, Mikio Browse this author |
Keywords: | Oseltamivir |
Zanamivir |
Laninamivir |
Peramivir |
Influenza A |
Influenza B |
Issue Date: | Jun-2018 |
Publisher: | Elsevier |
Journal Title: | Journal of infection and chemotherapy |
Volume: | 24 |
Issue: | 6 |
Start Page: | 449 |
End Page: | 457 |
Publisher DOI: | 10.1016/j.jiac.2018.01.013 |
PMID: | 29487035 |
Abstract: | The clinical effectiveness of four neuraminidase inhibitors (NAIs) (oseltamivir, zanamivir, laninamivir, and peramivir) for children aged 0 months to 18 years with influenza A and B were investigated in the 2014-2015 to 2016-2017 influenza seasons in Japan. A total of 1207 patients (747 with influenza A and 460 with influenza B) were enrolled. The Cox proportional-hazards model using all of the patients showed that the duration of fever after administration of the first dose of the NAI was shorter in older patients (hazard ratio = 1.06 per 1 year of age, p < 0.001) and that the duration of fever after administration of the first dose of the NAI was shorter in patients with influenza A infection than in patients with influenza B infection (hazard ratio = 2.21, p < 0.001). A logistic regression model showed that the number of biphasic fever episodes was 2.99-times greater for influenza B-infected patients than for influenza A-infected patients (p < 0.001). The number of biphasic fever episodes in influenza A-or B-infected patients aged 0-4 years was 2.89-times greater than that in patients aged 10-18 years (p = 0.010), and the number of episodes in influenza A-or B-infected patients aged 5-9 years was 2.13times greater than that in patients aged 10-18 years (p = 0.012). |
Rights: | © 2018. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/ |
Type: | article (author version) |
URI: | http://hdl.handle.net/2115/74500 |
Appears in Collections: | 北海道大学病院 (Hokkaido University Hospital) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|